Supportive therapy in COPD includes long-term oxygen therapy (LTOT) an
d patient support groups as two cornerstones in a comprehensive progra
m of care known as pulmonary rehabilitation. The rich history of LTOT
dating to the early 1960s and bolstered by excellent controlled clinic
al trials of the 1970s, along with additional advances, provided an ef
fective therapy which improved both the quality and length of life in
patients with COPD. Many patients with oxygen gain insight into coping
with advanced COPD through patient support groups. The need for more
cosmetically pleasing oxygen delivery systems to the nose, and future
directions in providing oxygen in the home, remain challenges.